Merck KGaA ( MKGAF) - Stock Earnings
MKGAF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 374.4 million USD | 6.2 billion USD |
| 2026Q1 | 759.2 million USD | 5.9 billion USD |
| 2026Q2 | 558.4 million USD | 6.2 billion USD |
| 2026Q4 Est. | — | — |
MKGAF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 3.1 billion USD | 23.2 billion USD |
| 2024 | 2.9 billion USD | 22.0 billion USD |
| 2025 | 3.1 billion USD | 24.8 billion USD |
| 2026 Est. | — | — |
MKGAF
Price: $154.25
Dividend Yield: 1.65%
Forward Dividend Yield: 1.22%
Payout Ratio: 35.47%
Dividend Per Share: 1.88 USD
Earnings Per Share: 6.74 USD
P/E Ratio: 24.26
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 67.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 31